Found: 9
Select item for more details and to access through your institution.
Trochlear nerve schwannoma with concomitant osimertinib-responsive stage IV lung adenocarcinoma: illustrative case.
- Published in:
- Journal of Neurosurgery Case Lessons, 2024, v. 8, n. 7, p. 1, doi. 10.3171/CASE24144
- By:
- Publication type:
- Article
Hypofractionated radiotherapy combined with bevacizumab plus low-dose ifosfamide, carboplatin, and etoposide as second-line chemoradiotherapy for progressing spinal diffuse midline glioma, H3K27-altered: illustrative case.
- Published in:
- Journal of Neurosurgery Case Lessons, 2024, v. 8, n. 7, p. 1, doi. 10.3171/CASE2464
- By:
- Publication type:
- Article
Seizure control by adding on other anti-seizure medication on seizure during levetiracetam administration in patients with glioma-related epilepsy.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11273-8
- By:
- Publication type:
- Article
Irreversible postoperative cognitive impairment after unruptured intracranial aneurysm treatment in the elderly.
- Published in:
- Acta Neurochirurgica, 2024, v. 166, n. 1, p. 1, doi. 10.1007/s00701-024-05933-2
- By:
- Publication type:
- Article
Irreversible postoperative cognitive impairment after unruptured intracranial aneurysm treatment in the elderly.
- Published in:
- Acta Neurochirurgica, 2024, v. 166, n. 1, p. 1, doi. 10.1007/s00701-024-05933-2
- By:
- Publication type:
- Article
Impact of tailored multimodal treatment for unruptured brain arteriovenous malformation: comparison with a randomized trial of unruptured brain arteriovenous malformations.
- Published in:
- Acta Neurochirurgica, 2023, v. 165, n. 12, p. 3779, doi. 10.1007/s00701-023-05815-z
- By:
- Publication type:
- Article
Author Correction: A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03917-5
- By:
- Publication type:
- Article
Development of extended pharmacokinetic models for propofol based on measured blood and brain concentrations.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-56863-z
- By:
- Publication type:
- Article